Reduced-drug or intermittent treatment reduced HIV drug costs by 29% between 2015 and 2022
Photo by Roger Pebody/AidsmapAlmost half of people with HIV receiving care at one of Paris’s largest HIV clinics received antiretroviral regimens consisting of two drugs or intermittent treatment in 2022 and drug reduction strategies almost halved the cost of HIV care between 2015 and 2022, Dr Luis Sagaon-Teyssier reported at the 19th European AIDS Conference (EACS 2023) in Warsaw.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
[Press release] FDA grants priority review of New Drug Application for Gilead’s once-daily HIV treatment of bictegravir plus lenacapavir
-
[CROI 2026] HIV i-Base: Investigational HIV combinations – daily, weekly, 4- and 6-monthly…
-
[Press release] FDA approves Merck’s once-daily IDVYNSO™ (doravirine/islatravir)
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.